Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, appointed Rob Schott, M.D., M.P.H, F.A.C.C., as Chief Medical Officer.
September 12, 2022
· 3 min read